Results 51 to 60 of about 23,895 (227)

Metastatic Spine Disease Alters Vertebral Load‐To‐Strength Ratios in Cancer Patients Compared to Healthy Individuals

open access: yesJOR SPINE, Volume 9, Issue 1, March 2026.
This study investigated the effect of spinal bone metastasis (BM) on the biomechanical environment of the spine through estimates of load, strength, and the load‐to‐strength ratio (LSR). Our study suggests that task‐specific differences related to cancer, lesion type, and vertebral location differentially affect the biomechanical environment of the ...
Dennis E. Anderson   +13 more
wiley   +1 more source

Developmental and functional effects of steroid hormones on the neuroendocrine axis and spinal cord [PDF]

open access: yes, 2016
This review highlights the principal effects of steroid hormones at central and peripheral levels in the neuroendocrine axis. The data discussed highlight the principal role of oestrogens and testosterone in hormonal programming in relation to sexual ...
Gonzalez Deniselle, Maria Claudia   +4 more
core   +2 more sources

Earlier Menopause and Risk of Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Global Cohort Study

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Objectives Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing public health concern that contributes to liver and cardiovascular complications. The prevalence of MASLD in women increases sharply around age 50 years, but the relationship between an earlier age at natural menopause and MASLD is unknown.
Joshua Stokar, Rivka Dresner‐Pollak
wiley   +1 more source

Serum prolactin revisited:parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia [PDF]

open access: yes, 2017
Background:Hyperprolactinemia diagnosis and treatment is often compromised by the presence of biologically inactive and clinically irrelevant higher-molecular-weight complexes of prolactin, macroprolactin.
Overgaard, Martin   +1 more
core   +2 more sources

Corticotroph Tumour Type Influences Clinical Behaviour in Patients With Nonfunctioning Pituitary Neuroendocrine Tumours

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Harbouring a silent corticotroph tumour (SCT) compared to a silent gonadotroph tumour, being older at surgery and having a larger preoperative tumour were found to increase the likelihood of having postoperative pituitary failure in logistic regression analysis (n = 77).
Nasrin Al‐Shamkhi   +5 more
wiley   +1 more source

The role of the stress hormone prolactin and sex differences in early psychosis [PDF]

open access: yes, 2017
In the last 20 years, a huge effort has been made to implement and apply the principles of early diagnosis and treatment, already well established in other branches of medicine, to the field of psychotic disorders. The goal of research on early detection
Ittig, Sarah
core   +1 more source

Radiological features of breast benign lesions in patients with hyperprolactinemia [PDF]

open access: yesArchive of Oncology, 2007
Background: The study was conducted to determine whether prolactin (PRL) influences radiological features of benign breast lesions. Methods: During the 4-year period, we observed 50 patients with nipple discharge: 23 with normal serum prolactin levels ...
Radojković Danijela   +5 more
doaj   +1 more source

Efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia: a Meta-analysis

open access: yesSichuan jingshen weisheng, 2023
ObjectiveTo systematically evaluate the efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia, and to provide references for intervention of antipsychotic-induced
Lan Xianjun   +6 more
doaj   +1 more source

Comparison of Side Effects Between 3‐Monthly and 1‐Monthly Paliperidone Palmitate Formulations in Patients With Schizophrenia

open access: yesHuman Psychopharmacology: Clinical and Experimental, Volume 41, Issue 1, January 2026.
ABSTRACT Background The paliperidone palmitate 3‐month (PP3M) formulation offers an extended dosing interval compared to the 1‐month (PP1M) formulation. However, data on the comparative side effect profiles of PP1M versus PP3M in real‐world settings remain limited.
Erkan Kuru   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy